©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Interaction of Nucleotides with the NAD(H)-binding Domain of the Proton-translocating Transhydrogenase of Rhodospirillum rubrum(*)

(Received for publication, December 1, 1995; and in revised form, February 5, 1996)

Tania Bizouarn (1) Christine Diggle (1) Philip G. Quirk (1) Rachel L. Grimley (1) Nick P. J. Cotton (1) Christopher M. Thomas (2) J. Baz Jackson (1)(§)

From the  (1)Schools of Biochemistry and (2)Biological Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Transhydrogenase catalyzes the reduction of NADP by NADH coupled to the translocation of protons across a membrane. The polypeptide composition of the enzyme in Rhodospirillum rubrum is unique in that the NAD(H)-binding domain (called Th(s)) exists as a separate polypeptide. Th(s) was expressed in Escherichia coli and purified. The binding of nucleotide substrates and analogues to Th(s) was examined by one-dimensional proton nuclear magnetic resonance (NMR) spectroscopy and by measuring the quenching of fluorescence of its lone Trp residue. NADH and reduced acetylpyridine adenine dinucleotide bound tightly to Th(s), whereas NAD, oxidized acetylpyridine adenine dinucleotide, deamino-NADH, 5`-AMP and adenosine bound less tightly. Reduced nicotinamide mononucleotide, NADPH and 2`-AMP bound only very weakly to Th(s). The difference in the binding affinity between NADH and NAD indicates that there may be an energy requirement for the transfer of reducing equivalents into this site in the complete enzyme under physiological conditions. Earlier results had revealed a mobile loop at the surface of Th(s) (Diggle, C., Cotton, N. P. J., Grimley, R. L., Quirk, P. G., Thomas, C. M., and Jackson, J. B. (1995) Eur. J. Biochem. 232, 315-326); the loop loses mobility when Th(s) binds nucleotide; the reaction involves two steps. This was more clearly evident, even for tight-binding nucleotides, when experiments were carried out at higher temperatures (37 °C), where the resonances of the mobile loop were substantially narrower. The binding of adenosine was sufficient to initiate loop closure; the presence of a reduced nicotinamide moiety in the dinucleotide apparently serves to tighten the binding. Two-dimensional ^1H NMR spectroscopy of the Th(s)-5`-AMP complex revealed nuclear Overhauser effect interactions between protons of amino acid residues in the mobile loop (including those in a Tyr residue) and the nucleotide. This suggests that, in the complex, the loop has closed down to within 0.5 nm of the nucleotide.


INTRODUCTION

Transhydrogenase couples the transfer of reducing equivalents between NAD(H) and NADP(H) to translocation of protons across a membrane(1, 2, 3) .

The enzyme is located in the cytoplasmic membrane of bacteria, where it is responsible for NADPH production during biosynthesis, and in the inner mitochondrial membrane, where it may serve in regulation of the tricarboxylic acid cycle by the protonmotive force(4) .

Transhydrogenase has separate catalytic binding sites for NAD(H) and for NADP(H)(5, 6, 7, 8) . These reside in relatively hydrophilic domains of the protein that protrude from the cytoplasmic side of the membrane (in bacteria). The NAD(H) site resides in domain I and the NADP(H) site in domain III(9) . The hydrophobic domain II spans the membrane. Several primary sequences of transhydrogenase are known. All are similar, although the polypeptide composition is variable (see (3) and (10) ). Uniquely, in Rhodospirillum rubrum transhydrogenase the NAD(H)-binding domain I exists as a separate polypeptide (called Th(s))(^1)(10, 11, 12) . This polypeptide, in dimeric form, can be dissociated from the domain II/III components of the enzyme. Separated Th(s) and the domain II/III proteins lack transhydrogenation activity but reconstitution leads to full recovery.

Recombinant Th(s) from R. rubrum was expressed at high levels in Escherichia coli(14) . The purified recombinant protein completely restored transhydrogenation activity to membranes of R. rubrum that had been washed to remove native domain I polypeptide. The characteristics of NADH binding to Th(s) were investigated by monitoring fluorescence quenching of a sole Trp residue at position 72 in the recombinant protein(14) . From an analysis of the one-dimensional ^1H NMR spectrum of Th(s), it was proposed that a region, which straddles sites that are highly sensitive to cleavage by proteases (Lys-Thr and Lys-Glu), has a significantly greater segmental flexibility than the remainder of the molecule(15) . This segment might be a mobile loop emanating from the surface of the protein. Some of the sharper resonances in the NMR spectrum were provisionally assigned to specific amino acids.

The well defined ^1H resonances attributed to amino acid residues within the mobile loop were considerably broadened and some were slightly shifted when either NAD or NADH were added to recombinant Th(s)(15) . This indicates that nucleotide binding causes a loss of loop mobility, and alters the rates of chemical exchange processes between conformations as the protons sample a range of environments on the NMR time scale. Titration with NAD revealed a two-step binding reaction. At low concentrations of nucleotide predominantly one resonance, the upfield Met at 1.97 ppm, was broadened. At higher concentrations, other mobile loop resonances also began to broaden. In titrations with NADH, relatively low nucleotide concentrations led to broadening of the mobile loop resonances. The resulting NMR spectrum was observed in the presence of higher concentrations of NAD.

In this report we describe the binding characteristics of NAD(H) analogues to Th(s) with a view to establishing nucleotide specificity and defining the conformational dynamics of the mobile loop during the nucleotide-binding reaction. Two-dimensional proton NMR spectra of the Th(s)-5`-AMP complex reveal interactions between nucleotide and protein.


MATERIALS AND METHODS

Preparation of the strain of E. coli bearing the recombinant Th(s) gene from R. rubrum, growth and induction of bacteria, and purification of the protein were carried out as described(14) . The procedure for preparing R. rubrum membrane vesicles depleted of native Th(s) was described(11) .

The factor used to correct protein concentrations in colorimetric assays (14) was found to be unreliable because traces of glycerol that were present, even after dialysis, resulted in an underestimate in the amino acid analysis of samples hydrolyzed with HCl. To ensure that protein estimations were correct, Th(s) (more than 95% pure according to SDS-polyacrylamide gel electrophoresis; (14) ) was estimated using two procedures, the microtannin assay (16) and the bicinchoninic acid assay(17) , which rely on different reactions of the protein, using bovine serum albumin as standard. The results were similar within 2%. In turn these concentrations were similar within 25% and 5%, respectively, to concentrations of solutions of native protein, and of protein denatured in 8 M urea, calculated from the absorbance at 280 nm, using an extinction coefficient predicted from the content of aromatic amino acids in Th(s). Routine measurements of the protein were subsequently estimated by the microtannin assay.

Fluorescence spectroscopy was performed with a Spex Fluoromax. Fluorescence signals were recorded at 25 °C in a stirred 1 times 1-cm cuvette using excitation and emission wavelengths of 280 nm and 310 nm, respectively. Slit widths were 1 mm. In titrations with nucleotides, inner filtering effects were compensated as described(14) .

Samples of Th(s) for NMR spectroscopy were prepared as described(15) . ^1H NMR spectra were recorded on a Bruker AMX500 spectrometer. One-dimensional pulse and collect spectra were acquired using a 10-ppm sweep width and comprised 256, 512, or 1024 transients of 16,000 data points with a total acquisition time of 45 min (or less; see figure legends). The temperature was 20 °C unless otherwise indicated. Spectral data were processed, prior to Fourier transformation, by application of an exponential multiplication factor corresponding to a line broadening of 1 Hz. In two-dimensional nuclear Overhauser effect spectroscopy (NOESY) experiments, 2000 data points were collected for 224 rows, each of 128 transients. Total acquisition time was 17 h.


RESULTS

Binding of Analogue Nucleotides to Th(s)

Acetylpyridine adenine dinucleotide is similar to NAD(H), except that it has an acetyl group at position 3 of the nicotinamide ring instead of a carboxamide(18) . The oxidized form, AcPdAD, is a good analogue of NAD in assays of ``reverse'' transhydrogenation. One-dimensional proton NMR experiments showed that binding of AcPdAD to Th(s) altered the conformational dynamics of the mobile loop in a similar way to physiological substrate (representative spectra are shown in Fig. 1; compare (15) ). Low concentrations of nucleotide (e.g.. 50-100 µM for 200 µM protein; Fig. 1B) led to an almost specific broadening of the upfield Met resonance at 1.97 ppm (denoted MetA; (22) ), whereas somewhat higher concentrations (100-1000 µM; Fig. 1C) were required to broaden other resonances assigned to the mobile loop, namely those at 1.22 ppm (CH(3) of Thr), 1.43 ppm (CH(3) of Ala), 2.06 ppm (CH(3) of MetC; see (22) ), 2.28 ppm (CH(2) of Glu), 6.82 and 7.12 ppm (3,5 and 2,6 ring protons, respectively, of Tyr), and 7.33 ppm (ring protons of Phe). In this higher concentration range, there were also small changes in the chemical shift of resonances, especially of aromatic protons, similar to those observed in the NAD titration. It was evident that AcPdAD, like NAD, binds to Th(s) in a two-step reaction. The first step is characterized by broadening of the upfield MetA resonance, and the second by broadening of other mobile loop resonances. AcPdAD resonances became detectable even at low concentrations (200 µM, Fig. 1), as described for NAD(15) . Thus, the sharp resonance at 2.22 ppm of CH(3) protons of the acetyl group of AcPdAD, in particular, but also resonances at 9.41, 9.14, 8.86, 8.45, 8.18, and 8.14 ppm (corresponding to the N-2, N-6, N-4, A-8, N-5, and A-2 protons) became clearly resolved at 200 µM nucleotide. Emerging nucleotide resonances were only slightly shifted and, with the interesting exception of A8 proton, not apparently broadened relative to those of nucleotide in buffer.


Figure 1: Representative one-dimensional ^1H NMR spectra recorded during a titration of Th(s) with AcPdAD. A, NMR spectrum of 200 µM Th(s) (512 transients), in 10 mM [^2H]Tris-Cl, p^2H 7.6, 10 mM (NH(4))(2)SO(4), 0.5 mM dithiothreitol in ^2H(2)O, at 20 °C, in the absence of nucleotides (note that the very sharp resonances at around 1.2-1.5 ppm are impurities); B, plus 50 µM AcPdAD; C, plus 400 µM AcPdAD. The p^2H was checked after nucleotide addition and, if necessary, adjusted to 7.6 with NaO^2H.



The reduced nucleotide, AcPdADH, binds to Th(s) and produces conformational changes in the mobile loop similar to those observed during NADH binding. 1) Addition of AcPdADH to a solution of Th(s) led to quenching of Trp fluorescence (Fig. 2). For similar concentrations of nucleotide, quenching was less extensive with AcPdADH than with NADH. Because of limitations imposed by inner-filtering effects of the nucleotides(14) , the K(d) of the analogue was difficult to determine with precision, but assuming the extent of fluorescence quenching at saturating AcPdADH was similar to that with NADH, the K(d) was approximately 40 µM (cf. approximately 20 µM for NADH; (14) ). 2) Titration of Th(s) with AcPdADH led to changes in the NMR spectrum similar to those observed in NADH titrations (Fig. 3; compare (15) ). Thus, low concentrations of nucleotide (30-100 µM for 122 µM protein) led to extensive broadening of resonances assigned to the mobile loop, i.e. those at 1.22, 1.43, 1.97, 2.06, 2.28, 6.82, 7.12, and 7.33 ppm (assigned as above). Also similar to NADH titration spectra, resonances of nucleotide protons were undetectable (due to line broadening) until high concentrations (>400 µM for 122 µM protein) of AcPdADH were added.


Figure 2: The quenching of fluorescence of the lone Trp of Th(s) by nucleotides. Experiments were performed with 0.6 µM Th(s) in a medium containing 10 mM Tris-HCl, pH8.0, 10 mM (NH(4))(2)SO(4), 1 mM dithiothreitol. The data are corrected for inner filtering effects (see ``Materials and Methods''). bullet, NADH; circle, AcPdADH; up triangle, deamino-NADH; , NAD.




Figure 3: Representative one-dimensional ^1H NMR spectra recorded during a titration of Th(s) with AcPdADH. For conditions, see Fig. 1. A, NMR spectrum of 122 µM Th(s) (512 transients), in the absence of nucleotides; B, plus 30 µM AcPdADH.



We speculated(15) , although it was not clearly evident from NMR spectra, that NADH as well as NAD might bind to Th(s) in a two-step process. Detection of the intermediate state might be difficult at 20 °C because of differences in rates of chemical exchange between reaction intermediates that involve reduced nucleotide. Experiments at 37 °C indicate that for both NADH and AcPdADH a two-step reaction can indeed be resolved. Reconstitution experiments with depleted membrane vesicles showed that Th(s) retains activity when incubated at 37 °C for >24 h. The NMR spectrum of Th(s) at 37 °C in the absence of nucleotides is shown in Fig. 4A. The resonances were much sharper than those at 20 °C (compare Fig. 1and Fig. 3), indicating that at higher temperatures the loop takes on even greater segmental mobility. Titration of Th(s) at 37 °C with either NADH (representative data in Fig. 4, B and C) or AcPdADH (data not shown) revealed the two-step binding reaction. At low concentrations of reduced nucleotide (20 µM; Fig. 4B), the MetA resonance at 1.97 ppm was shifted (0.02 ppm) upfield and was broadened more extensively than those attributable to Thr, Ala, Tyr, etc. in the mobile loop. At slightly higher concentrations of NADH (100 µM; Fig. 4C) or AcPdADH (data not shown), other loop resonances did become broadened.


Figure 4: Representative one-dimensional ^1H NMR spectra recorded at 37^o C during a titration of Th(s) with NADH. For conditions, see Fig. 1, except that the temperature was 37 °C. A, NMR spectrum of 240 µM Th(s) (256 transients), in the absence of nucleotides; B, plus 20 µM NADH; C, plus 100 µM NADH.



Deamino-NADH is modified in the adenine part and not in the nicotinamide part with respect to NADH. It had a small quenching effect on fluorescence from Trp of Th(s) (Fig. 2), but the K(d) was too large to measure. The weak binding of this analogue to Th(s) was also reflected by NMR data. Thus, features observed in NADH titrations were also seen with deamino-NADH, but at higher concentrations (about 2-fold for equivalent protein concentrations, not shown). The two-step reaction was evident, the MetA resonance broadening at lower nucleotide concentrations than other mobile loop resonances.

5`-AMP and adenosine are weak inhibitors of transhydrogenase(19) . Inhibition with 5`-AMP is competitive with respect to AcPdAD and mixed with respect to NADPH(5, 6, 8) . Remarkably, the effects of 5`-AMP and adenosine on the NMR spectrum of Th(s) were qualitatively very similar to those of NAD and AcPdAD; low concentrations specifically broadened and shifted slightly upfield the MetA resonance, and higher concentrations led to broadening of the other mobile loop resonances (data not shown). The nucleotide resonances became evident as narrow bands in the spectrum even at quite low concentrations of 5`-AMP and adenosine (e.g. 150 µM 5`-AMP for 200 µM protein).

Reduced nicotinamide mononucleotide (NMNH) corresponds to the complementary half of NADH to 5`-AMP. It did not quench fluorescence of Trp, and, up to 1 mM, either on its own or in combination with 400 µM 5`-AMP, NMNH had no effect on the NMR spectrum of Th(s) (data not shown).

In contrast to NADH, NADPH up to about 50 µM did not quench the fluorescence from Trp of Th(s) and addition of NADPH up to 200 µM had little effect on the NMR spectrum (data not shown). High concentrations of NADPH (around 1 mM) led to slight broadening. Again in contrast to NADH, the nucleotide resonances became evident as sharp bands, even at at low concentrations of NADPH (50 µM), during the titration with Th(s) (208 µM). Together, these data indicate that NADPH can bind into the NADH site, at best with only very low affinity, and the possibility is not ruled out that other contaminating nucleotide(s) in the NADPH solution cause the protein resonance broadening.

2`-AMP is an inhibitor of transhydrogenase(8, 5, 6, 19) , competitive with respect to NADPH and mixed with respect to AcPdAD. 2`-AMP had no effect on the NMR spectrum of Th(s), and nucleotide resonances were detectable at very low nucleotide concentrations (data not shown).

Effect of pH on NADH Binding to Th(s)

It has been speculated that coupling of transhydrogenation to the protonmotive force might be mediated through changes in the affinity of the enzyme for NAD(H)(20, 21) . If NAD(H) binding were coupled to proton translocation, then the binding affinity would have a strong pH dependence. However, Fig. 5shows that the K(d) Th(s) for NADH, as determined from the quenching of fluorescence of Trp, was independent of pH between 6.0 and 9.0. Because of inner filtering by NADH, reliable data can be collected only for the early part of the binding curve. This has the effect that the larger the value of K(d) the more it is subject to error, and the result shown in Fig. 5therefore reflects more reliably the lack of an increase in binding affinity with changing pH than the lack of a decrease in affinity.


Figure 5: The pH dependence of NADH binding to Th(s). Experiments were performed as in Fig. 2, except that instead of Tris-HCl, the medium contained 20 mM Ches, 20 mM Tricine, 20 mM Mops with the pH adjusted to that shown in the figure with NaOH. The concentration of Th(s) was 1.0 µM. K values were calculated from double-reciprocal plots of the corrected data.



The one-dimensional proton NMR spectrum of Th(s) at pH6.3 in cacodylate buffer (data not shown) was similar to that recorded in Tris-Cl buffer at pH7.6. The unassigned resonances between 7.6 and 7.9 ppm were slightly broader at the lower pH, which might indicate that they arise from His residues, but other resonances displayed a similar chemical shift and linewidth. Consistent with the lack of effect of pH on K(d), NMR spectra recorded during an NADH titration of Th(s) at pH6.3 (data not shown) were similar to those at pH7.6(15) .

Two-dimensional Proton NMR of the Th(s)-AMP Complex

The two-dimensional NOESY experiment detects interactions between protons close to one another in space (<0.5 nm), and can be used to build up a picture of the molecular structure in solution. The diagonal of the two-dimensional spectrum represents a contour plot of the one-dimensional spectrum, and NOE interactions appear as cross peaks located away from the diagonal. The interactions in our system may be either intramolecular (Th(s)-Th(s) or nucleotide-nucleotide) or intermolecular (Th(s)-nucleotide) ``transferred'' NOEs.

Th(s) bound to NADH was not suitable for NOESY experiments because of the extreme broadening of the resonances from both molecules at the high concentrations of NADH required(15) . The analogue 5`-AMP, with a lower binding affinity, was preferred. Experiments were performed on a mixture of Th(s) and 5`-AMP, control experiments on Th(s) and 5`-AMP alone. Very few NOE interactions were detected in Th(s) alone; interesting exceptions were from Tyr ring protons (see (22) for confirmation of this assignment) to a resonance at 4.52 ppm, likely to be the Tyr CalphaH (Fig. 6A). Additional cross-peaks were detected in the Th(s)/5`-AMP mixture, with the H8, H2, H1`, H4`, H5`, and H5" protons of 5`-AMP all showing interactions with protons of Th(s) (Fig. 6). Although absolute assignments are not possible, the H8 proton in particular appeared to interact with CalphaH of Tyr, a further CalphaH (possibly Lys or Ala), and side chain methylene and methyl groups. The Tyr ring proton-CalphaH interaction at 4.52 ppm in the absence of nucleotide (see above) was shifted to 4.58 ppm, and decreased in intensity, in the presence of 5`-AMP.


Figure 6: Two-dimensional ^1H NMR of Th(s). Experiments were performed as described in Fig. 1and under ``Materials and Methods.'' A, 200 µM Th(s) alone; B, plus 600 µM 5`-AMP. Controls with 600 µM 5`-AMP alone are not shown.




DISCUSSION

The reduced nucleotides, NADH and AcPdADH, bind more tightly to Th(s) than do the oxidized nucleotides, NAD and AcPdAD. (a) Low concentrations of NADH and AcPdADH quenched the fluorescence of Trp of the protein, whereas NAD and AcPdAD up to 50 µM did not; (b) equilibrium dialysis measurements (^2)give K(d) values for NADH consistent with those measured from Trp fluorescence quenching, and indicate higher values for NAD; (c) in NMR spectra recorded during titrations, the resonances of NADH and AcPdADH were broad until quite high concentrations were added to Th(s), but those of NAD and AcPdAD appeared as sharp bands even at quite low concentrations; and (d) resonances attributable to the mobile loop of Th(s) were broadened at relatively low concentrations of NADH and AcPdADH, but only at high concentrations of NAD and AcPdAD. In principle, NMR spectroscopy can be used to measure binding constants, but the mobile loop resonances of Th(s) are insufficiently resolved to allow the detailed analysis of linewidth and lineshape as a function of nucleotide concentration required for determination of the type of exchange and therefore accurate values of K(d). Nevertheless, the dependence of the amplitude of the reasonably resolved resonances (e.g. Thr, Ala, and Tyr) on nucleotide concentration should give a comparative indication of binding affinities: there could be a 5-10-fold difference in the K(d) values (K(d) > K(d) and K(d) > K(d)).

Supporting the conclusions from kinetic analyses(4, 5, 6, 7, 8) , the experiments with analogues indicate: (a) the adenosine moiety is crucial in the binding reaction and (b) the reduced nicotinamide moiety increases the binding affinity when it is part of the NADH molecule, but that, as a free entity, NMNH cannot occupy the binding site. The oxidized nicotinamide moiety seems barely to contribute to the affinity since, on the basis of the NMR spectra, NAD appeared to bind only a little more tightly than 5`-AMP and adenosine. The importance of the adenosine part is also highlighted by the observation that deamino-NADH bound more weakly than NADH. Different patterns of inhibition of the transhydrogenation reaction by 5`-AMP (an NAD(H) analogue) and 2`-AMP (an NADP(H) analogue) were instrumental in the development of the now established concept that the complete enzyme has separate sites for NAD(H) and NADP(H)(4, 5, 6, 7, 8, 19) . The observation from NMR spectra that, in contrast to 5`-AMP, 2`-AMP fails to bind to Th(s) is a complementary view of those inhibition patterns. That adenosine binds to Th(s) with the same order of affinity as 5`-AMP indicates that lack of the 5`-phosphate is not critical for binding, but comparison with the 2`-AMP results shows that presence of the 2`-phosphate blocks nucleotide binding at this site.

The finding that the binding affinity of Th(s) for NADH is substantially greater than that for NAD may be considered in the context of the operation of transhydrogenase under physiological conditions. If the enzyme operates in the direction of reduction of NADP by NADH, then it must bind NADH from, and release NAD to, an environment (the mitochondrial matrix or the bacterial cytoplasm) in which free NAD(H) is predominantly oxidized. Thus, tight binding of NADH to transhydrogenase, and weak binding of NAD, favor operation in this direction. The observation that the binding constants for NAD and NADH are different in Th(s) indicates that they are intrinsically different (K(d) > K(d)) also in the complete enzyme. If there is such a difference then, during turnover, energy will be required to populate the EbulletNADbulletNADPH state from EbulletNADHbulletNADP; this must derive exclusively from the protonmotive force (Deltap), since DeltaG for the overall chemical reaction under physiological conditions is positive. There is evidence that primary energy coupling in transhydrogenase is centered on the NADP(H) binding reaction within domains II and III; proton binding and release components of the proton translocation reaction are coupled directly to NADP binding and NADPH release, respectively (23, 24, 25) . Thus energy required to drive the unfavorable hydride transfer reaction (EbulletNADHbulletNADP EbulletNADbulletNADPH) must be derived from those primary events. It is proposed that conformational changes driven by the protolytic reactions that accompany NADP(H) binding and release promote the hydride transfer from NADH to NADP, either by making the NADH more reducing or by making the NADP more oxidizing (compare(26) ). In structural terms, interactions between protein side chains and nucleotide in the binding site in domain I must be relatively favorable for NADH and unfavorable for NAD; Deltap must drive hydride transfer against these unfavorable structural changes before the protein can release NAD. The DeltaG required to maintain the NAD/NADH ratio on the enzyme against a 10-fold increase in K(d) (K(d) = 20 µM; K(d) approx 200 µM; see above) is approximately 5.7 kJbulletmol. The energy available from a Deltap of 200 mV is 19.3 kJbulletmol (assuming one proton translocated per H transferred between nucleotides; (27) ). The balance of 13.6 kJbulletmol is available at the primary energy-coupling reaction to generate the change in binding constants for NADP(H) that are associated with protonation/deprotonation; this DeltaG is sufficient to increase K(d)/K(d) by 230-fold.

K(m) values of transhydrogenase for NADH and NAD are affected by membrane energization, and this was interpreted as evidence for a different model to the one above; it was thought that changes in K(m) might reflect changes in affinity for NADH and NAD during energization(20, 21) . However, caution is necessary when interpreting changes in K(m) for complex reactions whose mechanism is not understood. Thus, even within the framework of our model, in which there are no Deltap-dependent changes in the affinity for NAD or NADH, changes in the K(m) for these nucleotides are still expected(24) . Evidence that binding of NADH is not coupled to proton binding or release in the domain I protein of transhydrogenase is given under ``Results''; the K(d) of Th(s) for NADH (measured by quenching of Trp fluorescence) was independent of pH from 6.0 to 9.0 (Fig. 5), and there were no differences in NMR spectra recorded during NADH titrations at pH 6.3 and 7.6. Energy-linked changes in the binding affinity of either NAD or NADH during turnover cannot be ruled out, but (a) it is unnecessary to invoke them to describe known properties of the enzyme, and (b) Th(s) is a very stable, water-soluble protein, which readily restores transhydrogenation activity to depleted membranes, and thus it is reasonable to assume that its properties reliably reflect those of domain I in the complete enzyme.

The question arises as to the role of the mobile loop during catalytic turnover. An important observation (Fig. 6) of NOE interactions between a Tyr residue in Th(s) and 5`-AMP bound within the NAD(H) site indicates that the nucleotide and the amino acid residue are in close proximity. It is shown by mutagenesis that this is Tyr in Th(s)(22) . Thus, the earlier conclusion, that the loop loses segmental mobility when Th(s) binds NAD(H)(15) , can now be refined; upon binding nucleotide, the loop closes down on the surface of the protein such that some loop residues are very close (<0.5 nm) to the nucleotide.

The one-dimensional NMR data show a similar pattern of behavior for different nucleotides that bind to the NAD(H) site of Th(s). Evidently, this behavior is not triggered by the reduced nicotinamide moiety, which in this context only increases the binding affinity of the nucleotide, but by the adenosine group. In all cases the furthest upfield of the proton resonances attributed to Met residues (MetA) is especially sensitive to nucleotide binding; the resonance is broadened at lower concentrations of nucleotide than are required to broaden other loop resonances. The identity of this residue is not known, but Met is a good candidate(15) . It is proposed that, following binding of nucleotide, the protein adopts a conformation in which the chemical environment of protons in MetA has changed; for example the residue might lose mobility, resulting in a broader NMR signal. It is clear (e.g.. Fig. 4), particularly for NADH and AcPdADH, at 37 °C, that broadening of the MetA resonance occurs at nucleotide concentrations considerably lower than the protein concentration. Therefore, the exchange rate between the two conformational states is probably intermediate/fast for NADH on the NMR timescale and fast for NAD. The state in which the MetA resonance is specifically broadened probably represents an intermediate on the way to the conformation in which other resonances (the 2.06 ppm MetC resonance, and the Thr, Ala, Tyr, Phe resonances, etc.) are also broadened (15) ie. in which the loop has closed down on the NAD(H)-binding site. The NMR spectrum of this conformation is evidently more related to its solution concentration, and hence exchange with the intermediate state is relatively slow. The binding process can be summarized (15) by the following reaction.

This is consistent with the inverse relationship between the appearance of nucleotide resonances during titration of Th(s) with different nucleotides, and the broadening of loop resonances. For those that bind tightly (NADH and AcPdADH), nucleotide resonances are not resolved from base-line noise (i.e. they remain extensively broadened) until they are present at concentrations somewhat in excess of the protein, whereas loop resonances are broadened at very low concentrations of the nucleotide. For those which bind weakly (NAD and 5`-AMP) nucleotide resonances emerge from base-line noise as sharp bands even at quite low nucleotide concentrations; higher concentrations are needed to cause broadening of loop resonances. In titrations with NADPH and 2`-AMP (which do not bind significantly), their resonances were evident as narrow bands even at very low nucleotide concentrations. The broadening of nucleotide resonances probably results from decreased mobility upon binding to the protein and, in principle, may occur in both Th(s)-NAD(H) and Th(s)-NAD(H). The less extensive broadening of the more weakly-bound NAD and AcPdAD arises as a result of faster exchange, and/or because the solution concentration of the unbound nucleotide, for a given total concentration, is higher.

Fjellstrom et al.(28) developed a model of part of domain I of transhydrogenase, based on sequence similarities with known three-dimensional structures of NAD(H)-binding domains of dehydrogenases. They describe their model with a bound nucleotide, and thus it should be compared with the situation (see above) in which the NMR-visible mobile loop has closed down on the NAD(H) binding site. Unfortunately, no such feature is evident in the predicted structure of Fjellstrom et al. The segment of polypeptide chain that we define as the ``mobile loop'' is shown as a short loop at the C terminus of a predicted beta-strand (betaC) together with the N terminus of a predicted alpha-helix (alphaD)(28) . This feature is envisaged as pointing away from the bound nucleotide. In contradiction with NMR data, the E. coli equivalent of Tyr in the model is situated >0.5 nm from the bound nucleotide. The model of Fjellstrom et al. retains attractive features. Perhaps the choice of dihydropteridine reductase as template for alphaD, based only on its length and some homologies in the subsequent beta-strand (28) was inappropriate. It is conceivable that this segment is unique to transhydrogenase, which unlike the templates used by Fjellstrom et al. is a transmembrane ion pump.


FOOTNOTES

*
We acknowledge financial support from the Wellcome Trust and the Biotechnology and Biological Sciences Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed.

(^1)
The abbreviations used are: Th(s), the NAD(H)-binding peripheral membrane polypeptide (domain I) of transhydrogenase from R. rubrum; AcPdAD, acetyl pyridine adenine dinucleotide (oxidized form); deamino-NADH, nicotinamide hypoxanthine dinucleotide; NOESY, nuclear Overhauser effect spectroscopy; Ches, 2-(cyclohexylamino)ethanesulfonic acid; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; Mops, 4-morpholinepropanesulfonic acid.

(^2)
T. Bizouarn, unpublished results.


ACKNOWLEDGEMENTS

We are indebted to Drs. Barry A. Levine and Eva I. Hyde for generous advice and to Sarah J. Peake for help in the preparation of Th(s).


REFERENCES

  1. Jackson, J. B. (1991) J. Bioenerg. Biomembr. 23, 715-741 [Medline] [Order article via Infotrieve]
  2. Hatefi, Y., and Yamaguchi, M. (1992) in Molecular Mechanisms in Bioenergetics (Ernster, L., eds) pp. 265-281, Elsevier, Amsterdam
  3. Olausson, T., Fjellstrom, O., Meuller, J., and Rydstrom, J. (1995) Biochim. Biophys. Acta 1231, 1-19 [Medline] [Order article via Infotrieve]
  4. Sazanov, L. A., and Jackson, J. B. (1994) FEBS Lett. 344, 109-116 [CrossRef][Medline] [Order article via Infotrieve]
  5. Hanson, R. L. (1979) J. Biol. Chem. 254, 888-893 [Medline] [Order article via Infotrieve]
  6. Homyk, M., and Bragg, P. D. (1979) Biochim. Biophys. Acta 571, 201-217 [Medline] [Order article via Infotrieve]
  7. Enander, K., and Rydstrom, J. (1982) J. Biol. Chem. 257, 14760-14766 [Abstract/Free Full Text]
  8. Lever, T. M., Palmer, T., Cunningham, I. J., Cotton, N. P. J., and Jackson, J. B. (1991) Eur. J. Biochem. 197, 247-255 [Abstract]
  9. Yamaguchi, M., and Hatefi, Y. (1993) J. Biol. Chem. 268, 17871-17877 [Abstract/Free Full Text]
  10. Williams, R., Cotton, N. P. J., Thomas, C. M., and Jackson, J. B. (1994) Microbiology 140, 1595-1604 [Abstract]
  11. Cunningham, I. J., Williams, R., Palmer, T., Thomas, C. M., and Jackson, J. B. (1992) Biochim. Biophys. Acta 1100, 332-338 [Medline] [Order article via Infotrieve]
  12. Yamaguchi, M., and Hatefi, Y. (1994) J. Bioenerg. Biomembr. 26, 435-445 [Medline] [Order article via Infotrieve]
  13. Fisher, R. R., and Guillory, R. J. (1971) J. Biol. Chem. 246, 4679-4686 [Abstract/Free Full Text]
  14. Diggle, C., Hutton, M., Jones, G. R., Thomas, C. M., and Jackson, J. B. (1995) Eur. J. Biochem. 228, 719-726 [Abstract]
  15. Diggle, C., Cotton, N. P. J., Grimley, R. L., Quirk, P. G., Thomas, C. M., and Jackson, J. B. (1995) Eur. J. Biochem. 232, 315-326 [Abstract]
  16. Mejbaum-Katzenellenbogen, S., and Drobryszycka, W. J. (1959) Clin. Chim. Acta 4, 515-522
  17. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Anal. Biochem. 150, 76-85 [Medline] [Order article via Infotrieve]
  18. Woenckhaus, C., and Jeck, R. (1987) in Pyridine Nucleotide Coenzymes: Chemical, Biochemical, and Medical Aspects; Part A (Dolphin, D., Poulson, R., and Avramovic, O., eds) pp. 449-568, John Wiley & Sons, New York
  19. Rydstrom, J. (1977) Biochim. Biophys. Acta 463, 155-184 [Medline] [Order article via Infotrieve]
  20. Galante, Y. M., Lee, Y., and Hatefi, Y. (1980) J. Biol. Chem. 255, 9641-9646 [Abstract/Free Full Text]
  21. Hu, X., Zhang, J. W., Persson, A., and Rydstrom, J. (1995) Biochim. Biophys. Acta 1229, 64-72 [Medline] [Order article via Infotrieve]
  22. Diggle, C., Quirk, P. G., Bizouarn, T., Grimley, R. L., Cotton, N. P. J., Thomas, C. M., and Jackson, J. B. (1996) J. Biol. Chem. 271, 10109-10115 [Abstract/Free Full Text]
  23. Hutton, M. N., Day, J. M., and Jackson, J. B. (1994) Eur. J. Biochem. 219, 1041-1051 [Abstract]
  24. Bizouarn, T., Grimley, R. L., Cotton, N. P. J., Stilwell, S., Hutton, M., and Jackson, J. B. (1995) Biochim. Biophys. Acta 1229, 49-58 [Medline] [Order article via Infotrieve]
  25. Sazanov, L. A., and Jackson, J. B. (1995) Biochim. Biophys. Acta 1231, 304-312 [Medline] [Order article via Infotrieve]
  26. Grau, U. M., Trommer, W. E., and Rossman, M. G. (1981) J. Mol. Biol. 151, 289-307 [Medline] [Order article via Infotrieve]
  27. Bizouarn, T., Sazanov, L. A., Aubourg, S., and Jackson, J. B. (1996) Biochim. Biophys. Acta , in press
  28. Fjellstrom, O., Olausson, T., Hu, X., Kallebring, B., Ahmad, S., Bragg, P. D., and Rydstrom, J. (1995) Proteins: Struct. Funct. Genet. 21, 91-104 [Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.